• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Persistence of cisplatin-induced DNA interstrand crosslinking in peripheral blood mononuclear cells from elderly and young individuals.

作者信息

Rudd G N, Hartley J A, Souhami R L

机构信息

Department of Oncology, University College London Medical School, UK.

出版信息

Cancer Chemother Pharmacol. 1995;35(4):323-6. doi: 10.1007/BF00689452.

DOI:10.1007/BF00689452
PMID:7828275
Abstract

DNA interstrand crosslinks (ISCL) produced by the incubation of human peripheral blood mononuclear cells (PBMs) with cisplatin (CDDP) were measured in two populations of volunteers, one aged less than 25 years and the other, greater than 72 years. The technique of fluorometric alkaline elution was used to measure DNA interstrand crosslinking with time after a 1-h exposure to drug. The samples from the young group showed a more consistent pattern of crosslink formation and removal, with extensive, or in some cases complete, repair at 48 h. Those from the elderly group showed considerable inter-individual variation and significantly higher mean levels of crosslinking at 24 and 48 h. No samples showed complete repair at 48 h in this population. These results indicate an impaired DNA repair capacity in the cells from the elderly group. This may be a factor in the poor tolerance of chemotherapy in the ageing population.

摘要

相似文献

1
Persistence of cisplatin-induced DNA interstrand crosslinking in peripheral blood mononuclear cells from elderly and young individuals.
Cancer Chemother Pharmacol. 1995;35(4):323-6. doi: 10.1007/BF00689452.
2
Enhanced repair of DNA interstrand crosslinking in ovarian cancer cells from patients following treatment with platinum-based chemotherapy.铂类化疗治疗后患者卵巢癌细胞中DNA链间交联修复增强。
Br J Cancer. 2007 Oct 8;97(7):927-33. doi: 10.1038/sj.bjc.6603973. Epub 2007 Sep 11.
3
Kinetics of the formation and removal of cisplatin-DNA adducts in blood cells and tumor tissue of cancer patients receiving chemotherapy: comparison with in vitro adduct formation.接受化疗的癌症患者血细胞和肿瘤组织中顺铂-DNA加合物形成与去除的动力学:与体外加合物形成的比较。
Cancer Res. 1990 Dec 15;50(24):7887-94.
4
Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells.顺铂敏感和耐药的人卵巢癌细胞中铂-DNA加合物形成与清除和顺铂细胞毒性之间的关系。
Cancer Res. 1994 Nov 15;54(22):5911-6.
5
Formation and repair of 1,3-bis-(2-chloroethyl)-1-nitrosourea and cisplatin induced total genomic DNA interstrand crosslinks in human glioma cells.1,3-双(2-氯乙基)-1-亚硝基脲和顺铂诱导人胶质瘤细胞中全基因组DNA链间交联的形成与修复
Cancer Biochem Biophys. 1995 Jan;14(4):231-41.
6
Detection of DNA crosslinks in peripheral lymphocytes isolated from patients treated with platinum derivates using modified comet assay.采用改良彗星试验检测用铂类衍生物治疗的患者外周血淋巴细胞中的 DNA 交联。
Neoplasma. 2013;60(4):413-8. doi: 10.4149/neo_2013_053.
7
DNA damage and repair in peripheral blood lymphocytes from healthy individuals and cancer patients: a pilot study on the implications in the clinical response to chemotherapy.健康个体和癌症患者外周血淋巴细胞中的DNA损伤与修复:关于化疗临床反应影响的初步研究
Cancer Lett. 2006 Jul 28;239(1):84-97. doi: 10.1016/j.canlet.2005.07.025. Epub 2005 Sep 6.
8
DNA crosslinks, DNA damage and repair in peripheral blood lymphocytes of non-small cell lung cancer patients treated with platinum derivatives.铂类衍生物治疗的非小细胞肺癌患者外周血淋巴细胞中的 DNA 交联、DNA 损伤和修复。
Oncol Rep. 2014 Jan;31(1):391-6. doi: 10.3892/or.2013.2805. Epub 2013 Oct 23.
9
Influence of cellular factors and pharmacokinetics on the formation of platinum-DNA adducts in leukocytes of children receiving cisplatin therapy.细胞因子和药代动力学对接受顺铂治疗的儿童白细胞中铂-DNA加合物形成的影响。
Clin Cancer Res. 2001 Aug;7(8):2205-12.
10
Binding of nuclear proteins associated with mammalian DNA repair to the mitomycin C-DNA interstrand crosslink.与哺乳动物DNA修复相关的核蛋白与丝裂霉素C-DNA链间交联的结合。
Environ Mol Mutagen. 1998;31(1):70-81.

引用本文的文献

1
Engineering small-molecule and protein drugs for targeting bone tumors.设计用于靶向骨肿瘤的小分子和蛋白质药物。
Mol Ther. 2024 May 1;32(5):1219-1237. doi: 10.1016/j.ymthe.2024.03.001. Epub 2024 Mar 6.
2
Environmental Toxicity Assessment of Sodium Fluoride and Platinum-Derived Drugs Co-Exposure on Aquatic Organisms.氟化钠与铂类药物共同暴露对水生生物的环境毒性评估
Toxics. 2022 May 23;10(5):272. doi: 10.3390/toxics10050272.
3
Environmental Risk Assessment of Oxaliplatin Exposure on Early Life Stages of Zebrafish ().奥沙利铂暴露对斑马鱼幼鱼期的环境风险评估()

本文引用的文献

1
Altered DNA repair in fibroblasts from aged rats.
Gerontology. 1981;27(6):306-12. doi: 10.1159/000212490.
2
The role of DNA repair in the recovery of human cells from cisplatin toxicity.
Chem Biol Interact. 1981 Oct;37(1-2):245-61. doi: 10.1016/0009-2797(81)90181-2.
3
DNA cross-linking as an indicator of sensitivity and resistance of mouse L1210 leukemia to cis-diamminedichloroplatinum(II) and L-phenylalanine mustard.DNA交联作为小鼠L1210白血病对顺二氯二氨铂(II)和L-苯丙氨酸氮芥敏感性和抗性的指标。
Cancer Res. 1981 Feb;41(2):640-9.
4
Toxics. 2022 Feb 9;10(2):81. doi: 10.3390/toxics10020081.
4
Fanconi anemia-independent DNA inter-strand crosslink repair in eukaryotes.真核生物中非范可尼贫血途径的 DNA 链间交联修复。
Prog Biophys Mol Biol. 2020 Dec;158:33-46. doi: 10.1016/j.pbiomolbio.2020.08.005. Epub 2020 Aug 30.
5
Optimal Scheduling of Bevacizumab and Pemetrexed/Cisplatin Dosing in Non-Small Cell Lung Cancer.贝伐珠单抗与培美曲塞/顺铂给药的非小细胞肺癌最佳时间安排。
CPT Pharmacometrics Syst Pharmacol. 2019 Aug;8(8):577-586. doi: 10.1002/psp4.12415. Epub 2019 May 9.
6
Medicinal plants and their isolated phytochemicals for the management of chemotherapy-induced neuropathy: therapeutic targets and clinical perspective.药用植物及其分离的植物化学物质在化疗诱导的周围神经病管理中的应用:治疗靶点和临床视角。
Daru. 2019 Jun;27(1):389-406. doi: 10.1007/s40199-019-00255-6. Epub 2019 Mar 9.
7
Systemic anticancer therapy (SACT) for lung cancer and its potential for interactions with other medicines.肺癌的全身抗癌治疗(SACT)及其与其他药物相互作用的可能性。
Ecancermedicalscience. 2017 Sep 4;11:764. doi: 10.3332/ecancer.2017.764. eCollection 2017.
8
The SOS and RpoS Regulons Contribute to Bacterial Cell Robustness to Genotoxic Stress by Synergistically Regulating DNA Polymerase Pol II.SOS和RpoS调控子通过协同调节DNA聚合酶Pol II,增强细菌细胞对基因毒性应激的耐受性。
Genetics. 2017 Jul;206(3):1349-1360. doi: 10.1534/genetics.116.199471. Epub 2017 May 3.
9
Enhancing synthetic lethality of PARP-inhibitor and cisplatin in BRCA-proficient tumour cells with hyperthermia.通过热疗增强PARP抑制剂和顺铂在BRCA功能正常的肿瘤细胞中的合成致死性。
Oncotarget. 2017 Apr 25;8(17):28116-28124. doi: 10.18632/oncotarget.15922.
10
Sensitizing thermochemotherapy with a PARP1-inhibitor.用聚(ADP-核糖)聚合酶1抑制剂进行致敏热化疗。
Oncotarget. 2017 Mar 7;8(10):16303-16312. doi: 10.18632/oncotarget.11422.
Effect of age on sensitivity of human lymphocytes to radiation. A brief note.年龄对人淋巴细胞辐射敏感性的影响。简短报告。
Mech Ageing Dev. 1982 Jun;19(2):97-101. doi: 10.1016/0047-6374(82)90001-x.
5
Peripheral sensory neuropathy and cisplatin chemotherapy.周围感觉神经病变与顺铂化疗
Neurology. 1984 Jul;34(7):934-8. doi: 10.1212/wnl.34.7.934.
6
Fluorometric quantitation of single-stranded DNA: a method applicable to the technique of alkaline elution.单链DNA的荧光定量:一种适用于碱性洗脱技术的方法。
Anal Biochem. 1982 Dec;127(2):302-7. doi: 10.1016/0003-2697(82)90177-4.
7
The quantitative detection of various Pt-DNA-adducts in Chinese hamster ovary cells treated with cisplatin: application of immunochemical techniques.顺铂处理的中国仓鼠卵巢细胞中各种铂 - DNA加合物的定量检测:免疫化学技术的应用
Carcinogenesis. 1985 Apr;6(4):561-6. doi: 10.1093/carcin/6.4.561.
8
Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy.接受顺铂化疗的睾丸癌和卵巢癌患者中顺二氨二氯铂(II)(顺铂)-DNA链内加合物的定量分析。
J Clin Invest. 1986 Feb;77(2):545-50. doi: 10.1172/JCI112335.
9
High-dose cisplatin therapy in ovarian cancer.
Semin Oncol. 1985 Dec;12(4 Suppl 6):21-30.
10
Reevaluation of interaction of cis-dichloro(ethylenediamine)platinum(II) with DNA.顺二氯(乙二胺)铂(II)与DNA相互作用的重新评估
Biochemistry. 1986 Jul 1;25(13):3912-5. doi: 10.1021/bi00361a026.